FDA Panel Recommends Cefiderocol for Complicated UTI FDA Panel Recommends Cefiderocol for Complicated UTI
An FDA advisory committee recommended cefiderocol for complicated urinary tract infections, including pyelonephritis caused by gram-negative bacteria in patients with limited treatment options.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 17, 2019 Category: Consumer Health News Tags: Urology News Alert Source Type: news

Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Review (19 studies; n = 8443) found screening and treatment for asymptomatic bacteriuria during pregnancy was linked to reduced rates of pyelonephritis and low birth weights, but available evidence was not current. Benefits in non-pregnant adult populations were not found. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 2, 2019 Category: Consumer Health News Source Type: news

Diagnosing urinary tract infection in the emergency department: a cohort study using electronic health records
Conference abstract details findings of cohort study in 289 patients with suspected UTIs; 60-70% diagnosed with lower UTI or pyelonephritis lacked clinical/micro evidence. Antibiotics (ABs) were stopped in (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 29, 2019 Category: Consumer Health News Source Type: news

NICE Bites - urinary tract infections
This publication provides a summary of key prescribing points taken from the NICE guidelines for Pyelonephritis, Lower Urinary Tract Infection, Recurrent and Catheter-associated UTI (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 15, 2019 Category: Consumer Health News Source Type: news

Antibiotic treatment regimens - MIMS summary table updated
The MIMS quick reference table summarising adult antibiotic treatment regimens has been updated in accordance with recent NICE guidance relating to uncomplicated lower UTI, acute bacterial prostatitis and acute pyelonephritis; a new section on recurrent UTI has also been added. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

Pyelonephritis (acute): antimicrobial prescribing: NICE guideline [NG111
This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance. It was published in October 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 31, 2018 Category: Consumer Health News Source Type: news

Acute Pyelonephritis: A Three-Pillar Approach for Clinicians Acute Pyelonephritis: A Three-Pillar Approach for Clinicians
Dr Desai reviews a decision algorithm for treating patients with acute pyelonephritis, published in NEJM.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 18, 2018 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

InFocus: Where to Start for Pyelonephritis? Urinalysis, CT, Antibiotics, and Observation?
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - August 1, 2018 Category: Emergency Medicine Tags: InFocus Source Type: news

Meropenem-vaborbactam Effective for Complicated Urinary Tract Infection Meropenem-vaborbactam Effective for Complicated Urinary Tract Infection
The combination meropenem-vaborbactam is at least as effective as piperacillin-tazobactam for treating complicated urinary tract infection, including acute pyelonephritis, according to results from the TANGO trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 28, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Kidney Infection
(Pyelonephritis) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 9, 2018 Category: General Medicine Source Type: news

Your NEJM Group Today: Acute Pyelonephritis Clinical Pearls / PPIs & Stroke? / Connecticut Primary Care Opportunities
Here ' s what we chose for you from NEJM Group today: NEJM Resident 360: Clinical Pearls: What are the typical manifestations of acute pyelonephritis? What is... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 8, 2018 Category: Primary Care Source Type: news

Antimicrobial prescribing: Ceftazidime/avibactam
This evidence summary outlines the best available evidence for a new intravenous antimicrobial, ceftazidime/avibactam (Zavicefta). It is indicated for treating complicated intra-abdominal infections,complicated urinary tract infections, including pyelonephritis,hospital ‑acquired pneumonia, including ventilator‑associated pneumonia and infections caused by aerobic gram‑negative organisms in adults with limited treatment options. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 17, 2017 Category: Consumer Health News Source Type: news

FDA OKs Vabomere, New Antibacterial for Complicated UTI FDA OKs Vabomere, New Antibacterial for Complicated UTI
Vabomere contains meropenem and vaborbactam and is intended for adults with complicated UTI, including pyelonephritis, caused by susceptible Enterobacteriaceae.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 30, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

FDA Approves Vabomere (meropenem and vaborbactam) for Complicated Urinary Tract Infections
August 29, 2017 -- The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 29, 2017 Category: Drugs & Pharmacology Source Type: news